Evidence map›Paper›PMID 40579132›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2025

[Therapeutic mechanism of

Guoyong Li, Renling Li, Yiting Liu, Hongxia Ke, Jing Li, Xinhua Wang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guoyong LiState Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou University of Chinese Medicine; Guangzhou 510080, China.
Renling LiArtemisinin Research Center, Guangzhou University of Chinese Medicine; Guangzhou 510080, China.
Yiting LiuState Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou University of Chinese Medicine; Guangzhou 510080, China.
Hongxia KeState Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou University of Chinese Medicine; Guangzhou 510080, China.
Jing LiState Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou University of Chinese Medicine; Guangzhou 510080, China.
Xinhua WangState Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou University of Chinese Medicine; Guangzhou 510080, China.

Funding

National Natural Science Foundation of China 82004155
6 · The paper itself

Abstract

objectivesTo explore the therapeutic mechanism of

methodsThe chemical constituents of

resultsFifty-three chemical constituents were identified from

conclusionsPreliminary findings suggest that

Indexed as

ArctiumDrugs, Chinese HerbalPlant ExtractsPulmonary FibrosisAnimalsMetabolomicsMiceMolecular Docking SimulationNetwork PharmacologySignal TransductionDrugs, Chinese HerbalPlant ExtractsArctium lappaMAPKmetabolomicsnetwork pharmacologypost-viral pneumonia pulmonary fibrosis

Identifiers

PMID40579132
PMCPMC12204825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.